Novartis India Ltd — Board Meeting, 29-07-2025: Board Meeting

Novartis India's board has approved the financial results for the quarter ended June 30, 2025. Revenue from operations for the quarter stood at 87.55 Cr, with a profit of 27.62 Cr. The board also approved the appointment of M/s. D. C. Dave & Co. as Cost Auditors for FY 2025-26, with a remuneration of 0.015 Cr. This appointment and remuneration will be put to shareholder ratification via a postal ballot. This provides clarity on the company's recent financial performance and ensures compliance with audit requirements.